Brighton Jones’s Roivant Sciences ROIV Stock Holding History
Bought
Maintained
Sold
Other funds holding ROIV
Brighton Jones's ROIV Position: Q3 2026 in Review
Brighton Jones increased its Roivant Sciences (ROIV) stake by 1.3% in Q3 2026, buying an estimated $4.5K and bringing the position to 9,843 shares worth $360K. The position accounts for 0.01% of the portfolio, ranked #965.
Brighton Jones first reported a position in ROIV in Q1 2026 and has held it in 3 quarters since. 409 funds tracked by Wall St. Rank hold ROIV as of Q3 2026.
- Brighton Jones held 9,843 shares of Roivant Sciences worth $360K as of Q3 2026.
- Brighton Jones bought 124 Roivant Sciences shares in Q3 2026, an estimated $4.5K.
- Roivant Sciences made up 0.01% of Brighton Jones's portfolio in Q3 2026, its #965 holding.
- Brighton Jones first reported a position in Roivant Sciences in Q1 2026 and has held it in 3 quarters since.
- 409 funds tracked by Wall St. Rank held Roivant Sciences as of Q3 2026.
Based on Brighton Jones's 13F filing for Q3 2026, filed 3 Nov 2026.